secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0001193125-22-171530
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex presents at Jefferies conference on KEYNOTE-B84 study; no new data disclosed
--------------------------------------------------------------------------------

- Presented at Jefferies Healthcare Conference on June 10, 2022 at 10:30 a.m. ET.
- Presentation covered the KEYNOTE-B84 study of pepinemab (anti-SEMA4D) in HNSCC.
- Filing does not include any new clinical data or financial results.
- Corporate slide deck furnished as Exhibit 99.1, available on company website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312522171530/0001193125-22-171530-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312522171530/d314833d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-171530

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer